Gastrointestinal stromal tumors
Open Access
- 1 February 2019
- journal article
- research article
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 40 (2) , 126-130
Abstract
To evaluate the clinical presentations and immunohistochemical (IHC) properties of gastrointestinal stromal tumors (GISTs) and to compare them to internationally published data. Thirty-six patients diagnosed with GISTs between January 1997 and December 2015 were retrospectively studied in 2 tertiary hospitals. Immunohistochemical staining was carried out prospectively when it has not been completed fully at the beginning. Results: The median age of patients was 54 years (range; 17-81 years). Predominantly, we found more females were affected. The male to female ratio was 1:1.7. The most frequently affected organs were the stomach (63.8%) followed by small bowel (25%) and colorectal region (8.4%). Abdominal pain was the most frequent presentation in 33.3% of the patients then gastrointestinal (GI) bleeding in 30.5%. Most of the gastric GISTs were at early stages at presentation: stage 1 and II (60.8%), while in non-gastric GISTs, the tumor stage was advanced: stage III and IV (69.3%). The IHC characteristic of GIST in descending order showed positivity for vimentin (88.9%), CD117 (83.3%), CD34 (77.8%), Ki67 (63.9%), SMA (38.9%), desmin (27.8%), and S100 (19.4%). Gastrointestinal stromal tumors in our study demonstrates a major similar feature as the published international data. However, minor differences do exist in terms of clinical features and immunohistochemistry.Keywords
This publication has 18 references indexed in Scilit:
- Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studiesCancer Epidemiology, 2016
- Gastrointestinal Stromal Tumors, Version 2.2014Journal of the National Comprehensive Cancer Network, 2014
- An Evaluation of 2537 Gastrointestinal Stromal Tumors for a Proposed Clinical Staging SystemArchives of Surgery, 2009
- Molecular Approaches To Resolve Diagnostic Dilemmas: the Case of Gastrointestinal Stromal Tumor and LeiomyosarcomaFuture Oncology, 2007
- Gastrointestinal stromal tumourThe Lancet, 2007
- Gastrointestinal stromal tumors in Iceland, 1990–2003: The Icelandic GIST study, a population‐based incidence and pathologic risk stratification studyInternational Journal of Cancer, 2005
- PDGFRA Activating Mutations in Gastrointestinal Stromal TumorsScience, 2003
- Diagnosis of gastrointestinal stromal tumors: A consensus approachHuman Pathology, 2002
- Two Hundred Gastrointestinal Stromal TumorsAnnals of Surgery, 2000
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998